BioSpace News Archive

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2020 on Wednesday, August 5, 2020, after the market closes.

ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced it intends to release its second quarter, 2020 financial results before market open on Wednesday, August 12, 2020.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today provided unaudited financial results for the quarter ended June 30, 2020.

Tychan, a Singapore-based clinical-stage biotechnology company focused on developing life-saving treatments through disruptive technologies, announced today a publication in New England Journal of Medicine (NEJM) demonstrating the safety and efficacy for TY014, a novel monoclonal antibody candidate treatment for yellow fever (YF).

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer today announced that it will release its second quarter financial results on Thursday, August 5, 2020 after the market closes

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.

LKC Technologies is pleased to announce that the Brazilian Health Regulatory Agency (Anvisa) has granted approval of the RETeval® device and LKC Technologies’ Sensor Strips skin electrodes, making this a significant advancement in the preservation and enhancement of sight for patients in Brazil.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Neo Medical, a Swiss Medtech company developing value-based care solutions to achieve a more Functional Fusion in spinal surgery, announced today that a new study published in Interdisciplinary Neurosurgery has shown that its disruptive controlled fixation sterile packed NEO Pedicle Screw System™ of implants and instruments reduces operating room time by up to 29%* (23 minutes) and cost by 1,415€

CORRECTING and REPLACING Quidel to Present Virtually at the Canaccord Genuity 40 th Annual Growth Conference CORRECTION...Quidel Corporation SAN DIEGO--( BUSINESS WIRE )-- In the first paragraph, the date of the conference should read: Thursday, August 13, 2020 (instead of Wednesday, August 13, 2020). The corrected release reads: QUIDEL TO PRESENT VIRTUALLY AT THE CANACCORD GENUITY 40 th ANNUAL GROWTH CONFERENCE Quidel Corporation (NASDAQ: